To report the long-term safety and efficacy data of a third generation drug eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus after a follow-up period of 5 years.
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up / Wiemer, Marcus; Stoikovic, Sinisa; Samol, Alexander; Dimitriadis, Zisis; Ruiz-Nodar, Juan M; Birkemeyer, Ralf; Monsegu, Jacques; Finet, Gérard; Hildick-Smith, David; Tresukosol, Damras; Novo, Enrique Garcia; Koolen, Jacques J; Barbato, Emanuele; Danzi, Gian Battista. - In: CARDIOVASCULAR DIABETOLOGY. - ISSN 1475-2840. - 16:1(2017), p. 23. [10.1186/s12933-017-0500-3]
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
Barbato, EmanueleMembro del Collaboration Group
;
2017
Abstract
To report the long-term safety and efficacy data of a third generation drug eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus after a follow-up period of 5 years.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
